Skip to content

MAST Cedars-Sinai

default-logo
default-logo
  • Home
  • About Us
    • Team and Leadership
    • Contact Us
    • Current Research
    • FAQs
  • Clinical Trials
  • Media
    • Scientific Articles
    • In The News
    • Video Library
    • Events
  • DONATE
Cedars Sinai
You are currently viewing Diabetes Drugs May Affect Endoscopy Patients

Diabetes Drugs May Affect Endoscopy Patients

Patients who take a class of widely prescribed medications to manage diabetes and obesity may require extra preparations before undergoing upper endoscopy procedures, according to a new Cedars Sinai study.

Connect to the article

You Might Also Like

Read more about the article Dreaming of Wellness

Dreaming of Wellness

August 29, 2017
Read more about the article Deeper Dive Into the Gut Microbiome Shows Changes Linked to Body Weight

Deeper Dive Into the Gut Microbiome Shows Changes Linked to Body Weight

November 6, 2024
Read more about the article Diabetes Awareness Month

Diabetes Awareness Month

November 28, 2022

elert

elert

elert

Recent Posts

  • Echo test
    Echo test
    January 16, 2026/
    0 Comments
  • Deeper Dive Into the Gut Microbiome Shows Changes Linked to Body Weight
    Deeper Dive Into the Gut Microbiome Shows Changes Linked to Body Weight
    November 6, 2024/
    0 Comments
  • Study Reveals Ultraviolet Light Exposure Has Antiviral Effects on COVID-19 Variants
    Study Reveals Ultraviolet Light Exposure Has Antiviral Effects on COVID-19 Variants
    November 6, 2024/
    0 Comments

Newsletter

Get all the latest content delivered directly to your inbox.

Subscribe

Cedars Sinai

Privacy Policy

Terms of Use

Sitemap

Newsletter

Get all the latest content delivered directly to your inbox.

Subscribe

CONTACT INFO

  • Phone:310-423-0617Opens in your application
  • Email:mastprogram@cshs.orgOpens in your application
© Copyright 2022 MAST | Site by Echo-Factory

Click here to visit the official Cedars-Sinai page specifically for donations to the MAST Program.

If you prefer to communicate with us directly, please call us at 310-423-0617.

Thank you for your support.